<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01549483</url>
  </required_header>
  <id_info>
    <org_study_id>ABHR001</org_study_id>
    <nct_id>NCT01549483</nct_id>
  </id_info>
  <brief_title>Small Airways Disease in Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness (AHR)</brief_title>
  <acronym>ABHR</acronym>
  <official_title>Differences in Small Airways Disease Between Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study differences in small airways (&lt;2mm) parameters in
      asthma patients, subjects with asymptomatic airway hyperresponsiveness and healthy controls.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peripheral airway resistance measured with impulse oscillometry (IOS)</measure>
    <time_frame>visit 1</time_frame>
    <description>Difference between resistance at 5 Hz (R5) and resistance at 20 Hz (R20) (R5-20).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Small airway parameters</measure>
    <time_frame>visit 1</time_frame>
    <description>Forced expiratory flow between 25 and 75% of forced vital capacity (FEF25-75), alveolar nitric oxide (NO), residual volume (RV), RV/total lung capacity (TLC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mRNA expression in nasal epithelium</measure>
    <time_frame>visit 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral airway resistance measured during provocation test</measure>
    <time_frame>visit 2</time_frame>
    <description>Resistance at 5 Hz (R5) during a bronchial provocation test with methacholine</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Asthma</condition>
  <condition>Airway Hyperresponsiveness</condition>
  <arm_group>
    <arm_group_label>Asthma</arm_group_label>
    <description>asthmatic subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asymptomatic AHR</arm_group_label>
    <description>Asymptomatic subjects with airway hyperresponsiveness</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy controls, without airway hyperresponsiveness</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Nasal epithelium brushes for mRNA expression
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Out-patient clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for asymptomatic subjects with airway hyperresponsiveness (AHR) :

          -  Age between 18 and 65 years.

          -  Forced expiratory volume in one second (FEV1) &gt; 80% predicted post bronchodilator.

          -  Provocative concentration causing a 205 fall in FEV1 (PC20) methacholine &lt;8 mg/ml.

          -  No history of asthma or previous use of asthma medication.

        Inclusion criteria for asymptomatic subjects without AHR :

          -  Age between 18 and 65 years.

          -  FEV1 &gt; 80% predicted post bronchodilator.

          -  PC20 methacholine &gt;8 mg/ml.

          -  No history of asthma or previous use of asthma medication.

        Inclusion criteria for patients with asthma:

          -  Age between 18 and 65 years.

          -  FEV1 &gt; 80% predicted.

          -  PC20 methacholine â‰¤8 mg/ml.

          -  Doctor's diagnosis of asthma.

          -  No history of Chronic obstructive pulmonary disease (COPD).

        Exclusion Criteria:

          -  Use of inhaled or oral steroids, antihistamines, nedocromil, theophylline, leukotrien
             antagonists or long-acting beta-agonists for at least three weeks before the start of
             the study.

          -  Any disease that may affect the outcome of the study as judged by the Investigator.

          -  FEV1 &lt;1.2 liter.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maarten Van den Berge, M.D., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700 RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2012</study_first_posted>
  <last_update_submitted>January 15, 2015</last_update_submitted>
  <last_update_submitted_qc>January 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Groningen</investigator_affiliation>
    <investigator_full_name>Maarten van den Berge</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>airway hyperresponsiveness</keyword>
  <keyword>asymptomatic airway hyperresponsiveness</keyword>
  <keyword>small airways</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Hypersensitivity</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

